A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B
Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the activity of Antroquinonol in patients with chronic hepatitis B
Secondary Objective:
To assess the mechanism and cytokines change of Antroquinonol in patients with chronic
hepatitis B